Matrix Trust Company’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-172
Closed -$30.3K 106
2026
Q1
$31K Sell
172
-182
-51% -$31.1K 0.01% 93
2025
Q4
$50K Hold
354
0.01% 120
2025
Q3
$29K Sell
354
-28
-7% -$2.16K ﹤0.01% 165
2025
Q2
$24K Buy
382
+154
+68% +$9.11K ﹤0.01% 182
2025
Q1
$16K Buy
228
+44
+24% +$3.58K ﹤0.01% 214
2024
Q4
$16K Sell
184
-31
-14% -$3.09K ﹤0.01% 216
2024
Q3
$20K Buy
215
+84
+64% +$7.46K ﹤0.01% 136
2024
Q2
$13K Buy
131
+73
+126% +$8.68K ﹤0.01% 131
2024
Q1
$8K Buy
+58
New +$7.14K ﹤0.01% 75

Other funds holding ALB

Matrix Trust Company's ALB Position: Q2 2026 in Review

Matrix Trust Company sold out of Albemarle (ALB) in Q2 2026, closing a stake of 172 shares — an estimated $30.3K sold.

Matrix Trust Company first reported a position in ALB in Q1 2024 and held it in 9 quarters. The position peaked at $50K in Q4 2025. 113 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Matrix Trust Company reported no remaining Albemarle position as of Q2 2026 after selling out during the quarter.
  • Matrix Trust Company sold 172 Albemarle shares in Q2 2026, an estimated $30.3K.
  • Matrix Trust Company first reported a position in Albemarle in Q1 2024 and held it in 9 quarters.
  • Matrix Trust Company's Albemarle position peaked at $50K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.